+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Gomisin G

BP0684
62956-48-3
98%
Biopurify
Gomisin G is a drug candidate for treatment of cardiovascular disease, and it is a good substrate of CYP2C9, and can be easily affected by the inhibitors of CYP2C9. Gomisin G exhibits anti-tumor activities, it exhibits potent anti-HIV activity with EC50 and therapeutic index (TI) values of 0.006 microgram/mL and 300, respectively.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0684-10mg 10mg
BP0684-20mg 20mg
BP0684-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

STAT3 TNF NOS2 PTGS2 NFKB1 AKT1 IL6 MTOR
BCL2 STAT3 GSK3B EGFR TP53 NFKB1 AKT1 CCND1 MET CDK4 MTOR
TNF NFKB1 IL6 CCR5 POL

Product drug property prediction parameters

  • 101.9100

  • 3.9931

  • 3.9929

  • .0018

  • 2.5546

  • 9.8748

  • High

  • 93.8369

  • 3.8646

  • No

  • No

  • No

  • No

  • No

  • Yes

  • 0.0

  • Yes

  • Yes

  • Yes

  • Yes